Analysts predict that Trupanion Inc (NASDAQ:TRUP) will report $65.60 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Trupanion’s earnings, with estimates ranging from $65.30 million to $65.90 million. Trupanion posted sales of $51.34 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 27.8%. The company is expected to issue its next quarterly earnings report after the market closes on Tuesday, February 13th.
On average, analysts expect that Trupanion will report full-year sales of $65.60 million for the current year, with estimates ranging from $241.40 million to $242.00 million. For the next financial year, analysts forecast that the business will report sales of $295.10 million per share, with estimates ranging from $291.70 million to $298.50 million. Zacks’ sales calculations are an average based on a survey of research firms that cover Trupanion.
A number of research analysts have weighed in on the stock. BidaskClub upgraded shares of Trupanion from a “hold” rating to a “buy” rating in a research report on Monday, December 18th. Northland Securities restated a “buy” rating and set a $38.00 price objective on shares of Trupanion in a report on Thursday. Zacks Investment Research upgraded shares of Trupanion from a “hold” rating to a “buy” rating and set a $37.00 price objective on the stock in a report on Wednesday, November 8th. CL King initiated coverage on shares of Trupanion in a report on Tuesday, November 21st. They set a “neutral” rating on the stock. Finally, Canaccord Genuity restated a “buy” rating and set a $35.00 price objective (up previously from $29.00) on shares of Trupanion in a report on Tuesday, October 31st. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $31.33.
Trupanion (NASDAQ TRUP) traded up $0.09 on Thursday, reaching $31.53. The company’s stock had a trading volume of 356,078 shares, compared to its average volume of 248,719. Trupanion has a 52 week low of $13.88 and a 52 week high of $36.88. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.87 and a quick ratio of 1.87. The stock has a market capitalization of $947.16, a price-to-earnings ratio of -350.29 and a beta of 0.34.
In other news, Director Murray B. Low sold 3,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $31.14, for a total transaction of $93,420.00. Following the sale, the director now owns 197,281 shares of the company’s stock, valued at approximately $6,143,330.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Darryl Rawlings sold 3,500 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $34.36, for a total transaction of $120,260.00. Following the sale, the insider now directly owns 1,382,976 shares in the company, valued at approximately $47,519,055.36. The disclosure for this sale can be found here. Insiders have sold a total of 28,039 shares of company stock worth $868,823 in the last ninety days. Corporate insiders own 31.24% of the company’s stock.
Institutional investors and hedge funds have recently modified their holdings of the business. Wells Fargo & Company MN grew its position in Trupanion by 13.5% in the 2nd quarter. Wells Fargo & Company MN now owns 11,261 shares of the financial services provider’s stock valued at $252,000 after acquiring an additional 1,342 shares in the last quarter. California Public Employees Retirement System boosted its stake in shares of Trupanion by 3.7% in the 2nd quarter. California Public Employees Retirement System now owns 42,200 shares of the financial services provider’s stock valued at $944,000 after buying an additional 1,500 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of Trupanion by 2.4% in the 4th quarter. Bank of New York Mellon Corp now owns 79,000 shares of the financial services provider’s stock valued at $2,311,000 after buying an additional 1,818 shares during the period. Alliancebernstein L.P. boosted its stake in shares of Trupanion by 11.4% in the 2nd quarter. Alliancebernstein L.P. now owns 18,600 shares of the financial services provider’s stock valued at $416,000 after buying an additional 1,900 shares during the period. Finally, Nationwide Fund Advisors boosted its stake in shares of Trupanion by 52.7% in the 2nd quarter. Nationwide Fund Advisors now owns 12,694 shares of the financial services provider’s stock valued at $284,000 after buying an additional 4,380 shares during the period. 63.76% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: This report was originally published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.thelincolnianonline.com/2018/02/18/trupanion-inc-trup-expected-to-announce-quarterly-sales-of-65-60-million-updated.html.
Trupanion Company Profile
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.